Moshe Mittelman
- Hematology top 0.2%
- Acute Myeloid Leukemia Research 60
- Erythropoietin and Anemia Treatment 42
- Multiple Myeloma Research and Treatments 20
- Genetics top 0.5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 18
- Hemoglobinopathies and Related Disorders 18
- Chronic Lymphocytic Leukemia Research 17
- Immunology top 10%
- Complement system in diseases 11
- Emergency Medicine top 5%
- Hematological disorders and diagnostics 18
- Oncology top 10%
- Co-authors
- Drorit NeumannHoward S. OsterMax GassmannAliza ZeidmanGuillermo SanzAlan N. SchechterAmos CohenMiloslav Beran
- Cited by
- HematologyGeneticsImmunology
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Nucleic Acids Research (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- IsraelUnited StatesGermany
In The Last Decade
Moshe Mittelman
175 papers receiving 3.2k citations
Hit Papers
Peers
Comparison fields: 5 of 127
- Hematology 2.1k
- Genetics 1.0k
- Immunology 366
- Emergency Medicine 167
- Oncology 450
Countries citing papers authored by Moshe Mittelman
This map shows the geographic impact of Moshe Mittelman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moshe Mittelman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moshe Mittelman more than expected).
Fields of papers citing papers by Moshe Mittelman
This network shows the impact of papers produced by Moshe Mittelman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moshe Mittelman. The network helps show where Moshe Mittelman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Moshe Mittelman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 3 | |
| 4 | 2023 | 1 | |
| 5 | 2021 | 43 | |
| 6 | 2021 | 50 | |
| 7 | 2021 | 4 | |
| 8 | 2020 | 8 | |
| 9 | 2020 | 1 | |
| 10 | 2020 | 19 | |
| 11 | 2018 | 8 | |
| 12 | 2016 | 22 | |
| 13 | 2014 | 23 | |
| 14 | 2010 | 68 | |
| 15 | 2008 | 52 | |
| 16 | Late mortality and determinants in patients with heart failure and preserved systolic left ventricular function: the Israel Nationwide Heart Failure Survey. | 2007 | 17 |
| 17 | 2005 | 14 | |
| 18 | 2005 | 6 | |
| 19 | 1996 | 7 | |
| 20 | 1992 | 10 |
About Moshe Mittelman
Moshe Mittelman is a scholar working on Hematology, Genetics and Emergency Medicine, having authored 186 papers that have together received 3.3k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (60 papers), Erythropoietin and Anemia Treatment (42 papers), Multiple Myeloma Research and Treatments (20 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (18 papers), Hemoglobinopathies and Related Disorders (18 papers), Hematological disorders and diagnostics (18 papers), Chronic Lymphocytic Leukemia Research (17 papers) and Complement system in diseases (11 papers). The work is most often cited by research in Hematology (2.1k citations), Genetics (1.0k citations) and Immunology (366 citations). Moshe Mittelman has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Drorit Neumann, Howard S. Oster, Max Gassmann, Aliza Zeidman, Guillermo Sanz, Alan N. Schechter, Amos Cohen, Miloslav Beran, John M. Bennett and Bruce D. Cheson. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.